Literature DB >> 3479048

In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.

M J Ohm-Smith1, R L Sweet.   

Abstract

The MICs of the new antimicrobial agents cefmetazole, cefotetan, and amoxicillin-clauvulanic acid were compared with the MICs of other antimicrobial agents against anaerobic bacteria from endometrial cultures from women with pelvic inflammatory disease or endometritis. The activity of cefmetazole was similar to that of cefoxitin and generally greater than that of cefotetan. Amoxicillin-clavulanic acid was generally more active than all cephamycins tested.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3479048      PMCID： PMC174958          DOI： 10.1128/AAC.31.9.1434

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods.

Authors:  R N Jones; A L Barry; P C Fuchs; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

2.  (S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity.

Authors:  E DE Clercq; J Descamps; P DE Somer; A Holyacute
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

3.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  A novel selective broad-spectrum anti-DNA virus agent.

Authors:  E De Clercq; A Holý; I Rosenberg; T Sakuma; J Balzarini; P C Maudgal
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

5.  Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study.

Authors:  G Ruckdeschel
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

6.  Inhibitory activity of cefotetan and other beta-lactams against anaerobes.

Authors:  H Werner
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

7.  Clavulanic acid, a novel inhibitor of beta-lactamases.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

8.  Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.

Authors:  J C Lin; M C Smith; J S Pagano
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

9.  Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics.

Authors:  J Wüst; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

Review 10.  Hypothesis: the pathogenesis of AIDS. Activation of the T- and B-cell cascades.

Authors:  A S Evans
Journal:  Yale J Biol Med       Date:  1984 May-Jun
View more
  7 in total

1.  Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.

Authors:  M R Jacobs; S K Spangler; P C Appelbaum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

2.  Pharmacokinetics and dose proportionality of cefmetazole in healthy young and elderly volunteers.

Authors:  M T Borin; G R Peters; T C Smith
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

3.  Disposition of cefmetazole in healthy volunteers and patients with impaired renal function.

Authors:  C E Halstenson; D R Guay; J A Opsahl; C A Hirata; L S Olanoff; E Novak; H Ko; K S Cathcart; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

4.  Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

5.  Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.

Authors:  M Reig; A Moreno; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

6.  Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.

Authors:  M R Jacobs; S K Spangler; P C Appelbaum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.